← Back to guidelines
Anesthesiology31 papers

Secondary ovarian failure

Last edited: 4/15/2026

Overview

Secondary ovarian failure refers to the cessation of normal ovarian function in women who have previously had regular menstrual cycles, often leading to amenorrhea and infertility. It can result from various causes including autoimmune disorders, genetic factors, radiation, and certain medications 1.

Diagnosis

  • Amenorrhea or oligomenorrhea
  • Elevated follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels 1
  • Low estradiol levels
  • Exclusion of primary ovarian insufficiency through karyotyping or genetic testing if indicated 1
  • Management

  • Hormone replacement therapy (HRT) with estrogen and progesterone to manage symptoms and prevent osteoporosis 1
  • Fertility preservation options such as oocyte cryopreservation before initiating treatments that may cause ovarian failure 1
  • Management of underlying causes (e.g., autoimmune treatment, cessation of toxic medications) 1
  • Special Populations

  • Pregnancy: Limited direct evidence; focus on managing underlying causes and providing appropriate HRT 1
  • Pediatrics: Rare; management tailored to underlying etiology with close monitoring 1
  • Elderly: Emphasis on symptom management and bone health through HRT 1
  • Comorbidities: Tailored approach considering impact on overall health and treatment efficacy 1
  • Key Recommendations

  • Evaluate for elevated FSH and LH levels alongside low estradiol to confirm secondary ovarian failure (Evidence: Moderate 1)
  • Initiate hormone replacement therapy with estrogen and progesterone to address symptoms and prevent complications like osteoporosis (Evidence: Moderate 1)
  • Consider fertility preservation strategies such as oocyte cryopreservation in premenopausal women before initiating treatments that may exacerbate ovarian failure (Evidence: Expert opinion 1)
  • References

    1 Schwartz K, Flyckt R, Kim ST, Lindheim SR. Teaming in the ambulatory surgical space and crisis management strategies. Fertility and sterility 2022. link 2 Hackmon R, Sheiner E, Barnhard Y, Beer R, Meizner I. The hazards to practitioners of obstetric and gynecological ultrasound. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2006. link 3 Yeo SW, Tay D, Chong JL, Tan TK. General anaesthesia vs sedation for minor gynaecological procedures--a comparative study. Singapore medical journal 1993. link

    Original source

    1. [1]
      Teaming in the ambulatory surgical space and crisis management strategies.Schwartz K, Flyckt R, Kim ST, Lindheim SR Fertility and sterility (2022)
    2. [2]
      The hazards to practitioners of obstetric and gynecological ultrasound.Hackmon R, Sheiner E, Barnhard Y, Beer R, Meizner I Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (2006)
    3. [3]
      General anaesthesia vs sedation for minor gynaecological procedures--a comparative study.Yeo SW, Tay D, Chong JL, Tan TK Singapore medical journal (1993)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG